A Single Center, Open Label, Stepwise, Dose Profiling Study to Evaluate the Efficacy and Safety of Four Dose Regimens of Inhaled TPI ASM8 in Patients With Allergic Asthma.

Trial Profile

A Single Center, Open Label, Stepwise, Dose Profiling Study to Evaluate the Efficacy and Safety of Four Dose Regimens of Inhaled TPI ASM8 in Patients With Allergic Asthma.

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Nov 2012

At a glance

  • Drugs ASM 8 (Primary)
  • Indications Allergic asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 May 2012 Company added in the association field and additional lead trial centre identified as reported by ClinicalTrials.gov.
    • 04 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Feb 2010 Actual patient number (14) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top